Grainofsand..I think you have a strong logic in your numbers...there always market perception...
- as per webinar..I was surprised to see is more important then psoriasis and few other well known decreases..clearly I.dicates unmet needs and impacts valuation...
- good basis point is Kakaen 300 000 units done on a second year with population 3x smaller and different pricing
- good margin 60% , over 60mln sales in the first year, will put this stock into 1bln MC ...I think conservatively..
- exclusivity till 2040 + extra few years till other players even start comming in...
- For exclusive a d growing revenue PE over 15 is very conservative..
Ann: Investor Webinar Presentation, page-17
-
- There are more pages in this discussion • 53 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add BOT (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
38.5¢ |
Change
0.005(1.32%) |
Mkt cap ! $696.8M | |||
| Open | High | Low | Value | Volume |
| 38.0¢ | 39.5¢ | 37.5¢ | $4.475M | 11.63M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 3 | 37310 | 38.0¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 38.5¢ | 54981 | 2 |
View Market Depth
| Last trade - 16.10pm 16/07/2024 (20 minute delay) ? |
| BOT (ASX) Chart |